K Square Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 11-07-2024
- Paid Up Capital ₹ 0.20 M
as on 11-07-2024
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 60.47%
(FY 2022)
- Profit 165.45%
(FY 2022)
- Ebitda -5.96%
(FY 2022)
- Net Worth 16.12%
(FY 2022)
- Total Assets 2.87%
(FY 2022)
About K Square Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Rashmi Gupta, Vineeta, Nandita Tripathi, and One other member serve as directors at the Company.
- CIN/LLPIN
U51101UP2012PTC051000
- Company No.
051000
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2012
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at K Square Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rashmi Gupta  | Director | 14-Jun-2012 | Current |
| Vineeta | Director | 14-Jun-2012 | Current |
| Nandita Tripathi | Director | 05-Feb-2013 | Current |
| Sanjay Tripathi | Director | 05-Feb-2013 | Current |
Financial Performance of K Square Life Sciences.
K Square Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 60.47% increase. The company also saw a substantial improvement in profitability, with a 165.45% increase in profit. The company's net worth Soared by an impressive increase of 16.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of K Square Life Sciences?
In 2019, K Square Life Sciences had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chiranjeev Multispeciality Hospital Private LimitedActive 4 years 6 monthsNandita Tripathi and Sanjay Tripathi are mutual person
- Chiranjeev Medical Centre LlpActive 8 years 10 months
Nandita Tripathi and Sanjay Tripathi are mutual person
- Chiranjeev Medicalstores Private LimitedActive 4 years 6 months
Nandita Tripathi and Sanjay Tripathi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at K Square Life Sciences?
Unlock and access historical data on people associated with K Square Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of K Square Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped K Square Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
